On Demand PDA 578 Technical Report No. 79: Particulate Matter Control in Difficult to Inspect Parenterals

The purpose of this eLearning module is to clarify related USP and global pharmacopeia guidance surrounding difficult to inspect parenterals (DIP). This eLearning module will also provide best practices for DIP product life-cycle management, destructive testing, and trending to support USP and global pharmacopeia guidance. This online training module is self-paced.

1. Apply USP <790> Particle detection in injectables at your worksite to ensure the safe release of batches and ultimately increase the safety of patients using a life-cycle approach
2. Differentiate DIP manufacturing inspection and testing from that of parenteral solutions that are clear/transparent in color and container system
3. Synthesize the entire operation process of DIP inspection to improve particulate matter control within your plant’s manufacturing batch releases
4. Summarize the process of particulate matter detection in DIPs